Patent · US Active

P2X7 modulators

US11820770B2 · kind B2 · utility

1Cited by

25References

20Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Manuel Jesus Alcazar Vaca · Toledo, ES
Jose Ignacio Andres Gil · Madrid, ES
Christa C. Chrovian · Village of La Jolla, US
Heather R. Coate · San Diego, US
Meri De Angelis · Munich, DE
Curt A. Dvorak · Poway, US
Christine F. Gelin · San Diego, US
Michael A. Letavic · San Diego, US
Brad M. Savall · San Diego, US
Akinola Soyode-Johnson · San Diego, US
Brice M. Stenne · Village of La Jolla, US
Devin M. Swanson · Carlsbad, US

Key dates

Filing date	Jan 14, 2022
Grant date	Nov 21, 2023
Priority date	—
Expiry date	Jan 16, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to compounds of Formulas (I, IIa and IIb):The invention also relates to pharmaceutical compositions comprising compounds of Formulas (I, IIa and IIb). Methods of making and using the compounds of Formulas (I, IIa and IIb) are also within the scope of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.